FDA Approves Changes to Kaletra Label

"On January 28, [2015] FDA approved changes to the Kaletra (lopinavir/ritonavir) label to include dosing recommendations in pregnant women."   More information is available: FDA: Press release AIDSinfo: Patient fact sheet on Kaletra